MarketCap
Facebook
X
TelegramQuarterly report 2025-Q3
added 11-14-2025
Precipio Operating Cash Flow 2011-2026 | PRPO
Annual Operating Cash Flow Precipio
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -3.56 M | -7.72 M | -6.58 M | -7.43 M | -9.14 M | -6.75 M | -6.69 M | -959 K | -12.4 M | -13.7 M | -8.47 M | -10.2 M | 220 K |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 220 K | -13.7 M | -7.18 M |
Quarterly Operating Cash Flow Precipio
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | -44 K | - | - | - | -667 K | - | - | - | -1.58 M | - | -6.22 M | -3.98 M | -2.33 M | - | -5.14 M | -3.01 M | -1.26 M | - | -5.98 M | -3.56 M | -1.59 M | - | -7 M | -4.89 M | -1.88 M | - | -4.8 M | -3.61 M | -1.14 M | - | -4.48 M | -897 K | -326 K | - | -642 K | -390 K | -1.92 M | - | -9.44 M | -6.01 M | -3.51 M | - | -11.2 M | -7.26 M | -3.87 M | - | -6.33 M | -5.69 M | -3.33 M | - | -7.78 M | -5.2 M | -2.76 M | - | -899 K | 87 K | 51 K |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 87 K | -11.2 M | -3.6 M |
Operating Cash Flow of other stocks in the Diagnostics research industry
| Issuer | Operating Cash Flow | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Centogene N.V.
CNTG
|
-21.7 M | - | -6.23 % | $ 30.6 M |  Germany |
|
Akumin
AKU
|
65.4 M | - | -17.87 % | $ 25.9 M |  Canada |
 |
Brainsway Ltd.
BWAY
|
884 K | $ 13.65 | - | $ 99.4 M |  Israel |
 |
Castle Biosciences
CSTL
|
64.9 M | $ 25.83 | - | $ 717 M |  USA |
 |
Aspira Women's Health
AWH
|
-32.2 M | - | -6.19 % | $ 10.5 M | USA |
 |
DexCom
DXCM
|
1.44 B | $ 66.34 | - | $ 25.9 B | USA |
 |
Bioventus
BVS
|
74.7 M | $ 8.87 | - | $ 591 M | USA |
 |
Guardant Health
GH
|
-185 M | $ 87.18 | 1.98 % | $ 10.9 B | USA |
 |
Charles River Laboratories International
CRL
|
738 M | $ 151.97 | - | $ 7.53 B | USA |
 |
CareDx, Inc
CDNA
|
42 M | $ 17.32 | - | $ 923 M | USA |
 |
ICON Public Limited Company
ICLR
|
1.29 B | $ 97.61 | - | $ 8.05 B |  Irlanda |
 |
IQVIA Holdings
IQV
|
2.65 B | $ 164.89 | - | $ 28.3 B | USA |
 |
Accelerate Diagnostics
AXDX
|
-48.7 M | - | -61.36 % | $ 2.46 M | USA |
 |
Exact Sciences Corporation
EXAS
|
491 M | $ 103.85 | - | $ 19.6 B | USA |
 |
Global Cord Blood Corporation
CO
|
614 M | - | - | $ 399 M |  China |
 |
Genetic Technologies Limited
GENE
|
-5.66 M | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
-524 M | - | 0.12 % | $ 80.1 M | China |
 |
Fulgent Genetics
FLGT
|
21.1 M | $ 14.95 | - | $ 452 M | USA |
|
Biodesix
BDSX
|
-48.6 M | $ 17.29 | - | $ 2.24 B | USA |
 |
Anixa Biosciences
ANIX
|
-7.17 M | $ 2.84 | - | $ 92.2 K | USA |
 |
Neogen Corporation
NEOG
|
58.2 M | $ 9.11 | - | $ 1.98 B | USA |
 |
Danaher Corporation
DHR
|
6.42 B | $ 191.39 | - | $ 136 B | USA |
 |
Biocept
BIOC
|
-13.3 M | - | -13.05 % | $ 7.29 M | USA |
 |
Pacific Biosciences of California
PACB
|
-111 M | $ 1.36 | - | $ 408 M | USA |
 |
Heska Corporation
HSKA
|
-21.8 M | - | - | $ 1.31 B | USA |
 |
HTG Molecular Diagnostics
HTGM
|
-18.4 M | - | -20.0 % | $ 1.06 M | USA |
 |
Illumina
ILMN
|
837 M | $ 119.28 | - | $ 19 B | USA |
 |
Quest Diagnostics Incorporated
DGX
|
1.89 B | $ 198.94 | - | $ 22.1 B | USA |
 |
QIAGEN N.V.
QGEN
|
674 M | - | - | $ 10.6 B |  Niderland |
 |
Agilent Technologies
A
|
1.48 B | $ 111.83 | - | $ 34 B | USA |
 |
BioNano Genomics
BNGO
|
-68.9 M | $ 1.11 | - | $ 1.41 M | USA |
 |
DarioHealth Corp.
DRIO
|
-30.4 M | $ 8.42 | -6.44 % | $ 239 M | Israel |
 |
Lantheus Holdings
LNTH
|
390 M | $ 78.5 | - | $ 5.3 B | USA |
 |
Chembio Diagnostics
CEMI
|
-12.7 M | - | 0.22 % | $ 16.8 M | USA |
 |
Check-Cap Ltd.
CHEK
|
-8 M | - | - | $ 9.42 M | Israel |
 |
Co-Diagnostics
CODX
|
-22.1 M | $ 4.4 | 101.83 % | $ 129 M | USA |
 |
Medpace Holdings
MEDP
|
713 M | $ 453.64 | - | $ 13.1 B | USA |
 |
Twist Bioscience Corporation
TWST
|
-47.6 M | $ 45.01 | - | $ 2.69 B | USA |
 |
Motus GI Holdings
MOTS
|
-11.2 M | - | -34.28 % | $ 263 K | Israel |
 |
Mettler-Toledo International
MTD
|
956 M | $ 1 198.71 | - | $ 24.7 B |  Schweiz |
 |
Celcuity
CELC
|
-83.5 M | $ 114.9 | - | $ 4.53 B | USA |
 |
DermTech
DMTK
|
-77 M | - | -11.32 % | $ 2.94 M | USA |
 |
National Research Corporation
NRC
|
26.4 M | $ 17.4 | - | $ 389 M | USA |
 |
NeoGenomics
NEO
|
5.23 M | $ 8.24 | - | $ 1.06 B | USA |
 |
Invitae Corporation
NVTA
|
-493 M | - | - | $ 21.2 M | USA |
 |
Enzo Biochem
ENZ
|
-26.3 M | - | -8.98 % | $ 14.8 K | USA |
 |
Natera
NTRA
|
-432 M | $ 197.68 | - | $ 19.5 B | USA |